TBPMF News and Press, Tetra Bio-Pharma Inc From 06/24/19

Tetra Bio-Pharma Inc. Announces Pricing of Unit Offering Canada NewsWire OTTAWA, June 24, 2019 /NOT FOR DISTRIBUTION TO THE UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES / OTTAWA , June 24, 2019 /CNW/ - Tetra Bio-Pharma Inc . (" Tetra "...

Tetra Bio-Pharma Inc. Announces Voting Results of 2019 Annual General and Special Meeting Canada NewsWire ORLEANS, ON, June 21, 2019 ORLEANS, ON , June 21, 2019 /CNW Telbec/ - Tetra Bio-Pharma Inc . (" Tetra " or the " Corporation ") (TSX VENTURE: TBP) (OTCQB: ...

Tetra Bio-Pharma Inc. Announces Proposed Offering of Units Canada NewsWire OTTAWA, June 19, 2019 /NOT FOR DISTRIBUTION TO THE UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES / OTTAWA , June 19, 2019 /CNW Telbec/ - Tetra Bio-Pharma Inc...

OTTAWA - June 18, 2019 (Investorideas.com Newswire) Tetra Natural Health, a subsidiary of Tetra Bio-Pharma ( TSX V: TBP ) ( OTCQB: TBPMF ), today announced that it has signed an exclusive agreement with Spyder Cannabis Inc. (TSX VENTURE: SPDR) ("Spyder") to distribute the three flavors of its He...

OTTAWA, June 18, 2019 (GLOBE NEWSWIRE) -- Tetra Natural Health, a subsidiary of Tetra Bio-Pharma (TSX VENTURE: TBP) (OTCQB: TBPMF), today announced that it has signed an exclusive agreement with Spyder Cannabis Inc. (TSX VENTURE: SPDR) (“ Spyder ”) to distribute the three flav...

U.S. granted patent protection for ophthalmic use; U.S. granted patent protection for topical delivery, increased drug solubility and abuse deterrence; U.S. FDA provides positive response on painful dry eye development program; Panag completes a Phase 3 clinical trial for...

Tetra Bio-Pharma Inc. Announces Change of Annual General Meeting Time Canada NewsWire ORLEANS, ON, June 17, 2019 ORLEANS, ON , June 17, 2019 /CNW Telbec/ -  Tetra Bio-Pharma Inc . (" Tetra " or the " Corporation ") (TSXV: TBP) (OTCQB: TBPMF), a global leader in ...

OTTAWA, June 17, 2019 (GLOBE NEWSWIRE) -- Tetra Bio-Pharma Inc ., (“ Tetra ” or the “ Company ”) a leader in cannabinoid-derived drug discovery and development (TSX VENTURE:TBP) (OTCQB:TBPMF) today announced that it conducted a Type B meeting with the United Sta...

Tetra Bio-Pharma Inc. Announces Director Resignation Canada NewsWire ORLEANS, ON, June 14, 2019 ORLEANS, ON , June 14, 2019 /CNW/ - Tetra Bio-Pharma Inc. (" Tetra " or the " Corporation ") (TSXV: TBP) (OTCQB: TBPMF), a global leader in cannabinoid-based drug develo...

OTTAWA, June 11, 2019 (GLOBE NEWSWIRE) -- Panag Pharma Inc., a subsidiary of Tetra Bio-Pharma Inc. (" Tetra " or the " Company ") (TSX-V: TBP) (OTCQB: TBPMF), today announced completion of Panag 001, its Phase 3 clinical trial evaluating the safety and efficacy of Topical-A, now brande...